CoChat

Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis

Open access
Halbritter, Florian, Farlik, Matthias, Schwentner, Raphaela, Jug, Gunhild, Fortelny, Nikolaus, Schnöller, Thomas, Pisa, Hanja, Schuster, Linda C., Reinprecht, Andrea, Czech, Thomas, Gojo, Johannes, Holter, Wolfgang, Minkov, Milen, Bauer, Wolfgang M., Simonitsch-Klupp, Ingrid, Bock, Christoph, Hutter, Caroline · 2019 · Cancer Discovery
Cited by 67

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Langerhans cell histiocytosis (LCH) is a rare neoplasm predominantly affecting children. It occupies a hybrid position between cancers and inflammatory diseases, which makes it an attractive model for studying cancer development. To explore the molecular mechanisms underlying the pathophysiology of LCH and its characteristic clinical heterogeneity, we investigated the transcriptomic and epigenomic diversity in primary LCH lesions. Using single-cell RNA sequencing, we identified multiple recurrent types of LCH cells within these biopsies, including putative LCH progenitor cells and several subsets of differentiated LCH cells. We confirmed the presence of proliferative LCH cells in all analyzed biopsies using IHC, and we defined an epigenomic and gene-regulatory basis of the different LCH-cell subsets by chromatin-accessibility profiling. In summary, our single-cell analysis of LCH uncovered an unexpected degree of cellular, transcriptomic, and epigenomic heterogeneity among LCH cells, indicative of complex developmental hierarchies in LCH lesions. Significance: This study sketches a molecular portrait of LCH lesions by combining single-cell transcriptomics with epigenome profiling. We uncovered extensive cellular heterogeneity, explained in part by an intrinsic developmental hierarchy of LCH cells. Our findings provide new insights and hypotheses for advancing LCH research and a starting point for personalizing therapy. See related commentary by Gruber et al., p. 1343. This article is highlighted in the In This Issue feature, p. 1325

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-19-0138

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 67

Metadata

Authors
Halbritter, F., Farlik, M., Schwentner, R., Jug, G., Fortelny, N., Schnöller, T., Pisa, H., Schuster, L. C., Reinprecht, A., Czech, T., Gojo, J., Holter, W., Minkov, M., Bauer, W. M., Simonitsch-Klupp, I., Bock, C., & Hutter, C.
Venue
Cancer Discovery
Published
2019-10-01
Volume
9
Issue
10
Pages
1406-1421
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W2964254974
Cited by
67
References
12
FWCI
4.86
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis. https://app.cochat.ai/papers/10.1158/2159-8290.cd-19-0138
The paper
Halbritter, F., Farlik, M., Schwentner, R., Jug, G., Fortelny, N., Schnöller, T., Pisa, H., Schuster, L. C., Reinprecht, A., Czech, T., Gojo, J., Holter, W., Minkov, M., Bauer, W. M., Simonitsch-Klupp, I., Bock, C., & Hutter, C. (2019). Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-19-0138

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.